By William Gorta ( September 2, 2016, 6:28 PM EDT) -- A California judge tossed the second amended complaint in a putative class action alleging securities fraud on Friday, saying that opinions and public information in blog posts about Cellular Biomedicine Group Inc.'s paid stock promotion campaign were inadequate to establish loss causation....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.